The University of Central Lancashire is proud to present its portfolio of Intellectual Property which covers a wide range of categories, including: Biomedical Sciences, Electrical and Electronic Engineering, Mechanical Engineering, Forensic Sciences, Nuclear Sciences, Materials and Nano-Materials Technologies, Tribology Technologies, Pharmacy and 3D Printing Technologies.
You can review the portfolio here or for more detail about a specific UCLan technology and answers to general questions about working with us or licensing our IP, please contact the innovation team at: email@example.com
UCLan research is developing solutions for the medical equipment market and in particular a dilator product for use in a clinical and home setting.
UCLan`s patented technology enables the removal of pollutants through the use of a relatively inexpensive water-purifying composite material and processing technology that is environmentally benign.
UCLan research has developed novel nanopowders which exhibit colour-tuneability in response to the wavelength of the incident radiation.
UCLan has developed and patented a series of new molecules that we hope one day could be advanced into a much needed new treatment for malignant brain tumours.
UCLan research is developing Rapidly Mutating (RM) YSTRs can differentiate between closely related males. A 13 locus multiplex PCR kit RM-YPlex was developed to simultaneously amplify them, in a robust and sensitive manner down to 0.0625ng template DNA.
UCLan patented research is developing new high performance fingerprint powders. These new powders have been developed from the surface modification of silica nano particles.
UCLan patented research using intelligent signal processing is being used to non-invasively track the increase of fluid in a bladder.
UCLan patented research is utilising aptamers, ligand-binding fragments of aptamers, and oligonucleotides for use as agents in the prevention and/or treatments of cancers, and diagnosis of cancers.